Abiopharma

New Form 8-K - TACTILE SYSTEMS TECHNOLOGY INC Filed: 2025-08-04 AccNo: 0001558370-25-010096 Size: 792 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - Altimmune, Inc. Filed: 2025-08-04 AccNo: 0001104659-25-073624 Size: 5 KB

New Form SCHEDULE 13G/A - MYRIAD GENETICS INC Filed: 2025-08-04 AccNo: 0001104659-25-073620 Size: 18 KB

New Form D - InspireMD, Inc. Filed: 2025-08-04 AccNo: 0001641172-25-022037 Size: 16 KB

New Form 8-K - BIOMARIN PHARMACEUTICAL INC Filed: 2025-08-04 AccNo: 0001048477-25-000088 Size: 810 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Semler Scientific, Inc. Filed: 2025-08-04 AccNo: 0001554859-25-000042 Size: 743 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - Quanterix Corp Filed: 2025-08-04 AccNo: 0001562180-25-005615 Size: 8 KB

New Form 144 - Twist Bioscience Corp Filed: 2025-08-04 AccNo: 0001959173-25-004923 Size: 7 KB

New Form 144 - IONIS PHARMACEUTICALS INC Filed: 2025-08-04 AccNo: 0001972481-25-000157 Size: 9 KB

New Form 8-K - Syndax Pharmaceuticals Inc Filed: 2025-08-04 AccNo: 0000950170-25-101974 Size: 7 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits